Remaining on preventive antiplatelet therapy with aspirin significantly increases the risk of bleeding complications in patients undergoing partial nephrectomy, according to research presented at the European Association of Urology annual congress in Madrid, Spain.
Percutaneous irreversible electroporation is showing promise as a novel minimally invasive approach for treating small renal tumors, according to the experience of urologists at the University of Texas Southwestern Medical Center, Dallas.
If further work with irreversible electroporation refines its capacity for discrete tissue ablation deep within the kidney and adjacent to large blood vessels, and especially if larger tumors can be addressed, then this would be a major step forward in the minimally invasive treatment of localized renal cancer.
Urologists at the University of Southern California’s Institute of Urology in Los Angeles are taking robotic kidney surgery to a new level. Inderbir S. Gill, MD, MCh, executive director of the USC Institute of Urology, has pioneered the use of the robot in patients with complex (level III) inferior vena cava thrombi.